LATEST NEWS

A letter from President and CEO Erica Ollmann Saphire, Ph.D.
A letter from Eric Zwisler, Chair, La Jolla Institute for Immunology Board of Directors
Mexican sculptor assembles an emotional tribute to COVID-19 research
Immune cells called monocytes offer clues to treating cancers, heart disease and more
Even elderly survivors show a strong, persistent immune memory
Annie Elong Ngono, Ph.D., is an infectious disease specialist at La Jolla Institute for Immunology, where she works to find answers to the biggest immunological questions.
Joel Martin, Ph.D., MBA, has joined La Jolla Institute for Immunology (LJI) as Managing Director and Chief Business Officer.
LJI-led Coronavirus Immunotherapeutic Consortium identifies antibody 'communities' with power to stop SARS-CoV-2 variants
New evidence indicates that target cells may play a role in their own destruction.
Weiskopf reflects on nearly two years of non-stop COVID-19 research—and a recent honor from her native Austria
Immune system memory stays strong 6+ months post-vaccination, similar to responses in recovered COVID-19 patients
"These cells might make a big difference in fighting off viruses"